Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Neoplasms, Pancreas
Interventions
BIOLOGICAL

cancer stem cell vaccine

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02074046 - Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer | Biotech Hunter | Biotech Hunter